Instrument: DE30 Technical Analysis Bullish Preference: Buy position is envisaged if price trades above 13911.8 with take profit at 13937.2 Bearish Preference: Sell position is envisaged if price trades below 13851.0 with take profit at 13825.9 Fundamentals:No major fundamental Comment:European stock markets edged higher Tuesday, helped by strong earnings from mining giant BHP Group ahead of the release of key German …
Instrument: US30 Technical Analysis Bullish Preference: Buy position is envisaged if price trades above 34402 with take profit at 34469 Bearish Preference: Sell position is envisaged if price trades below 34326 with take profit at 34267 Fundamentals:No major Fundamental. Comment: Investors were also bracing for a barrage of earnings that will help them assess the impact of the Ukraine war and a …
Instrument: GBPUSD Technical Analysis Bullish Preference: Buy position is envisaged if price trades above 1.35817 with take profit at 1.35946 . Bearish Preference: Sell position is envisaged if price trades below 1.35645 with take profit at 1.35522 . Fundamentals:3:45pm USD Flash Manufacturing PMIUSD Flash Services PMI4:00pm USD CB Consumer Confidence Comment: The GBP/USD pair kicked off the new week on a …
Instrument: GBPUSD Technical Analysis Bullish Preference: A Buy position is envisaged if price trades above 1.33447 with take profit at 1.33572. Bearish Preference: A Sell position is envisaged if price trades below price 1.33305 with take profit at 1.33173. Fundamentals:3:45pm USD Chicago PMI4:00pm USD Fed Chair Powell TestifiesUSD CB Consumer ConfidenceUSD Treasury Sec Yellen Speaks7:00pm USD FOMC Member Clarida …
Instrument: USDCAD Technical Analysis Bullish Preference: Buy position is envisaged if price trades above 1.27515 with take profit at 1.27628. Bearish Preference: Sell position is envisaged if price trades below 1.27200 with take profit at 1.27087. Fundamentals:Tentative USD Treasury Currency Report Comment: USD/CAD refreshes intraday high to 1.2693 to mark the first positive day in the last four with 0.36% …
Instrument: US100 Technical Analysis Bullish Preference: Buy position is envisaged if price trades above 16649.71 with take profit at 16694.79 Bearish Preference: Sell position is envisaged if price trades below 16593.36 with take profit at 16552.04 Fundamentals:No major fundamental Comment: U.S. stocks are seen opening bullish albeit trend not clearly established, The previous week wrapped up with investors focusing …
Instrument: US100 Technical Analysis Bullish Preference: Buy position is envisaged if price trades above 16082.67 with take profit at 16099.82 Bearish Preference: Sell position is envisaged if price trades below 16028.41 with take profit at 16012.47 Fundamentals:4pm USD JOLTS Job OpeningsUSD Prelim UoM Consumers Sentiments Comment: Stock futures moved slightly higher early Friday morning as Wall Street looked to …
Instrument: GOLD Technical Analysis Bullish Preference: Buy position is envisaged if price trades above 1861.11 with take profit at 1864.93. Bearish Preference: Sell position is envisaged if price trades below 1853.26 with take profit at 1848.78. Fundamentals:4pm USD JOLTS Job OpeningsUSD Prelim UoM Consumers Sentiments Comment: Gold was down on Friday morning in Asia, but was set for its biggest weekly …
Instrument: USDCAD Technical Analysis Bullish Preference: A Buy position is envisaged if price trades above 1.26060 with take profit at 1.26178. Bearish Preference: A Sell position is envisaged if price trades below price 1.25756 with take profit at 1.25636. Fundamentals:3:00pm USD ISM Services PMI6:15pm USD FOMC Member Quarles Speaks Comment: The pair struggled to capitalize on its early positive move and …
Instrument: US100 Technical Analysis Bullish Preference: Buy position is envisaged if price trades above 15349.43 with take profit at 15366.71. Bearish Preference: Sell position is envisaged if price trades below 15279.49 with take profit at 15263.05. Fundamentals:USD All Day Jackson Hole SymposiumUSD 1:30PM- Prelim GDP q/q Comment: Investors have turned more positive on the outlook since the U.S. Food and Drug Administration fully …
